Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.240
-0.220 (-8.94%)
At close: Apr 28, 2026, 4:00 PM EDT
2.340
+0.100 (4.46%)
After-hours: Apr 28, 2026, 7:41 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $25.11 million as of April 28, 2026. Its market cap has decreased by -27.47% in one year.
Market Cap
25.11M
Enterprise Value
15.07M
1-Year Change
-27.47%
Ranking
Category
Stock Price
$2.24
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has decreased from $30.33M to $25.11M, a decrease of -17.22%. That is a compound annual growth rate of -3.16%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lisata Therapeutics | 28.90M |
| Kyntra Bio | 28.89M |
| Apollomics | 28.52M |
| BriaCell Therapeutics | 28.09M |
| Polyrizon | 27.74M |
| Longeveron | 27.52M |
| NanoViricides | 27.21M |
| Neuphoria Therapeutics | 27.17M |